Switch to Bing in English
Copilot
Your everyday AI companion
About 10,300 results
  1. Systemic Lupus Erythematosus - StatPearls - NCBI …

    WEBAug 4, 2023 · Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with multisystemic involvement. The condition has several phenotypes, with varying clinical presentations from mild …

    • Author: Angel A. Justiz Vaillant, Amandeep Goyal, Pankaj Bansal, Matthew Varacallo
    • Published: 2023/08/04
    • Publish Year: 2021
  2. 欧州リウマチ学会(EULAR)SLE治療推奨2023 | 昭和大学病院 ...

  3. People also ask
    Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with multisystemic involvement. The condition has several phenotypes, with varying clinical presentations from mild mucocutaneous manifestations to multiorgan and severe central nervous system involvement. Several immunopathogenic pathways play a role in the development of SLE.
    As SLE is a complex heterogeneous disease with different cytokines involved in its pathogenesis, it is highly unlikely that inhibition of only one molecule, such as IL-17, will be effective in the treatment of all clinical manifestations. Future studies should identify SLE patients that are eligible for Th17-targeted therapy.
    Basophils have been implicated in systemic lupus erythematosus (SLE), as evidenced by the fact that basophil-deficient mice do not develop the disease. Here, the authors demonstrate that PD-L1 and IL-4 expression in basophils promotes the pathogenic accumulation of follicular helper T cells in patients with SLE and murine models.
    Complements C3 and C4 shall be checked in patients with SLE or suspicion of SLE, and low complement levels indicate complement consumption and may correlate with disease activity. Markers of inflammation such as erythrocyte sedimentation rate and C-reactive protein may be elevated.
  4. Symptoms, diagnosis and treatment - BMJ Best Practice

  5. 全身性エリテマトーデス(SLE)の治療の選択肢と日 …

    WEBDec 8, 2023 · 全身性エリテマトーデスSLE )の薬物治療では、副腎皮質ホルモンというステロイドが中心であり、主にプレドニゾロンという薬を使うことが多くなっています。 ステロイドが使われる前の死亡率は今よりも高く、4割を超えていたとされていますが、ステロイドをきちん …

  6. PD-L1- and IL-4-expressing basophils promote pathogenic ...

  7. 【世界初】「全身性エリテマトーデス」発症メカニズムを一部 ...

  8. 全身性エリテマトーデス(SLE)とはどのような病 …

    WEBDec 8, 2023 · 全身性エリテマトーデス ( SLE )は全身に起こる 自己免疫疾患 の一種で、顔に特徴的な 湿疹 しっしん がみられることが知られています。 全身性エリテマトーデスSLEの症状や診断治療に対する考え方などについて国立病院機構 横浜医療センター 膠原病 ・リウマチ …

  9. 全身性エリテマトーデス(SLE)患者への支援内容とは:訪問 ...

  10. Association of Toll-Like Receptor 7 (TLR7) Polymorphisms with ...

  11. Is Th17-Targeted Therapy Effective in Systemic Lupus ...

By using this site you agree to the use of cookies for analytics, personalized content, and ads.Learn more about third party cookies|Microsoft Privacy Policy